Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUALGRAFT: Delayed Infusion of Engineered Hematopoietic Graft in Solid Organ Transplant Recipients
NCT06997471Phase 1Recruiting
- Start
- Jun 2025
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in solid organ transplant rejection (SOTR) and solid organ transplant complications. Primary endpoint: Incidence of adverse events related to the investigational intervention at 2 years. Started Jun 2025; status: recruiting.
02
Conditions
solid organ transplant rejection (SOTR)solid organ transplant complications
Beyond the preview
Go deeper on NCT06997471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06997471.